nantkwest

NEWS

Recent News

NantKwest Announces Pricing of Public Offering of Common Stock

EL SEGUNDO, Calif.--Jun. 25, 2020-- NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock (3,700,000 shares...

NantKwest Announces Proposed Public Offering of Common Stock

EL SEGUNDO, Calif.---Jun. 24, 2020-- NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an...

Overcoming Hypoxia-Induced Functional Suppression of NK Cells

Kristen Solocinski 1, Michelle R Padget 1, Kellsye P Fabian 1, Benjamin Wolfson 1, Fabiola Cecchi 2, Todd Hembrough 2, Stephen C Benz 3, Shahrooz Rabizadeh 2 4, Patrick Soon-Shiong 2 4, Jeffrey Schlom 1, James W Hodge 5 Affiliations expand PMID: 32345623 PMCID:...

Recent News

NantKwest Announces Pricing of Public Offering of Common Stock

EL SEGUNDO, Calif.--Jun. 25, 2020-- NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock (3,700,000 shares...

NantKwest Announces Proposed Public Offering of Common Stock

EL SEGUNDO, Calif.---Jun. 24, 2020-- NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an...

Overcoming Hypoxia-Induced Functional Suppression of NK Cells

Kristen Solocinski 1, Michelle R Padget 1, Kellsye P Fabian 1, Benjamin Wolfson 1, Fabiola Cecchi 2, Todd Hembrough 2, Stephen C Benz 3, Shahrooz Rabizadeh 2 4, Patrick Soon-Shiong 2 4, Jeffrey Schlom 1, James W Hodge 5 Affiliations expand PMID: 32345623 PMCID:...

Current Events

Archives

Media Contact:

Jen Hodson
NantKwest
Telephone: 562-397-3639
Email: Press@NantKwest.com